CareDx reported a decrease of 7% in revenue compared to Q1 2023, but a 10% increase compared to Q4 2023. The company is raising its full year 2024 revenue guidance to $274 million to $282 million.
First quarter revenue was reported at $72.0 million.
Testing Services revenue reached $53.8 million, a 15% increase compared to the fourth quarter 2023.
Testing services patient results grew for the third consecutive quarter to approximately 42,000, a 6% increase compared to the fourth quarter 2023.
The company ended the quarter with approximately $216 million in cash, cash equivalents, and marketable securities, with no debt.
CareDx is raising guidance for the full year 2024 revenue which is expected to be in the range of $274 million to $282 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance